vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and STEWART INFORMATION SERVICES CORP (STC). Click either name above to swap in a different company.

STEWART INFORMATION SERVICES CORP is the larger business by last-quarter revenue ($764.6M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.2%, a 4.6% gap on every dollar of revenue. On growth, STEWART INFORMATION SERVICES CORP posted the faster year-over-year revenue change (27.7% vs -1.7%). Over the past eight quarters, STEWART INFORMATION SERVICES CORP's revenue compounded faster (12.7% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Stewart Information Services Corporation (SISCO) is a real estate information, title insurance and transaction management company. Wholly owned subsidiaries, Stewart Title Guaranty Co. and Stewart Title Company offer products and services in the United States and abroad through its direct retail operations, independent agencies in the Stewart Trusted Provider network, and other companies. Stewart Title is headquartered in Houston, Texas, and has approximately 6,350 employees.

MD vs STC — Head-to-Head

Bigger by revenue
STC
STC
1.5× larger
STC
$764.6M
$493.8M
MD
Growing faster (revenue YoY)
STC
STC
+29.4% gap
STC
27.7%
-1.7%
MD
Higher net margin
MD
MD
4.6% more per $
MD
6.8%
2.2%
STC
Faster 2-yr revenue CAGR
STC
STC
Annualised
STC
12.7%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MD
MD
STC
STC
Revenue
$493.8M
$764.6M
Net Profit
$33.7M
$17.0M
Gross Margin
Operating Margin
9.9%
Net Margin
6.8%
2.2%
Revenue YoY
-1.7%
27.7%
Net Profit YoY
10.5%
448.4%
EPS (diluted)
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
STC
STC
Q1 26
$764.6M
Q4 25
$493.8M
$790.6M
Q3 25
$492.9M
$796.9M
Q2 25
$468.8M
$722.2M
Q1 25
$458.4M
$612.0M
Q4 24
$502.4M
$665.9M
Q3 24
$511.2M
$667.9M
Q2 24
$504.3M
$602.2M
Net Profit
MD
MD
STC
STC
Q1 26
$17.0M
Q4 25
$33.7M
$36.3M
Q3 25
$71.7M
$44.3M
Q2 25
$39.3M
$31.9M
Q1 25
$20.7M
$3.1M
Q4 24
$30.5M
$22.7M
Q3 24
$19.4M
$30.1M
Q2 24
$-153.0M
$17.3M
Operating Margin
MD
MD
STC
STC
Q1 26
Q4 25
9.9%
6.5%
Q3 25
13.8%
7.7%
Q2 25
12.8%
6.5%
Q1 25
7.0%
1.0%
Q4 24
7.8%
5.3%
Q3 24
6.6%
6.4%
Q2 24
-31.3%
4.8%
Net Margin
MD
MD
STC
STC
Q1 26
2.2%
Q4 25
6.8%
4.6%
Q3 25
14.5%
5.6%
Q2 25
8.4%
4.4%
Q1 25
4.5%
0.5%
Q4 24
6.1%
3.4%
Q3 24
3.8%
4.5%
Q2 24
-30.3%
2.9%
EPS (diluted)
MD
MD
STC
STC
Q1 26
Q4 25
$0.40
$1.26
Q3 25
$0.84
$1.55
Q2 25
$0.46
$1.13
Q1 25
$0.24
$0.11
Q4 24
$0.37
$0.81
Q3 24
$0.23
$1.07
Q2 24
$-1.84
$0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
STC
STC
Cash + ST InvestmentsLiquidity on hand
$375.2M
$317.5M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
Total Assets
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
STC
STC
Q1 26
$317.5M
Q4 25
$375.2M
$369.7M
Q3 25
$340.1M
$233.2M
Q2 25
$224.7M
$223.8M
Q1 25
$99.0M
$194.2M
Q4 24
$229.9M
$257.5M
Q3 24
$103.8M
$228.7M
Q2 24
$19.4M
$176.7M
Total Debt
MD
MD
STC
STC
Q1 26
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
$445.8M
Q3 24
Q2 24
Stockholders' Equity
MD
MD
STC
STC
Q1 26
Q4 25
$865.9M
$1.6B
Q3 25
$890.7M
$1.5B
Q2 25
$833.8M
$1.4B
Q1 25
$789.2M
$1.4B
Q4 24
$764.9M
$1.4B
Q3 24
$732.5M
$1.4B
Q2 24
$706.5M
$1.4B
Total Assets
MD
MD
STC
STC
Q1 26
Q4 25
$2.2B
$3.3B
Q3 25
$2.2B
$2.8B
Q2 25
$2.1B
$2.8B
Q1 25
$2.0B
$2.7B
Q4 24
$2.2B
$2.7B
Q3 24
$2.1B
$2.7B
Q2 24
$2.0B
$2.6B
Debt / Equity
MD
MD
STC
STC
Q1 26
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
0.32×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
STC
STC
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
STC
STC
Q1 26
Q4 25
$114.1M
$89.5M
Q3 25
$137.3M
$92.6M
Q2 25
$137.2M
$53.4M
Q1 25
$-117.5M
$-29.9M
Q4 24
$133.0M
$68.0M
Q3 24
$91.8M
$76.1M
Q2 24
$107.0M
$21.1M
Free Cash Flow
MD
MD
STC
STC
Q1 26
Q4 25
$62.3M
Q3 25
$73.6M
Q2 25
$38.7M
Q1 25
$-42.2M
Q4 24
$55.6M
Q3 24
$67.4M
Q2 24
$11.9M
FCF Margin
MD
MD
STC
STC
Q1 26
Q4 25
7.9%
Q3 25
9.2%
Q2 25
5.4%
Q1 25
-6.9%
Q4 24
8.4%
Q3 24
10.1%
Q2 24
2.0%
Capex Intensity
MD
MD
STC
STC
Q1 26
Q4 25
3.4%
Q3 25
2.4%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
1.9%
Q3 24
1.3%
Q2 24
1.5%
Cash Conversion
MD
MD
STC
STC
Q1 26
Q4 25
3.39×
2.47×
Q3 25
1.91×
2.09×
Q2 25
3.49×
1.67×
Q1 25
-5.66×
-9.73×
Q4 24
4.36×
2.99×
Q3 24
4.72×
2.53×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

STC
STC

Agency title$333.0M44%
Direct title$270.2M35%
Real estate solutions$161.4M21%

Related Comparisons